Skip to search formSkip to main contentSkip to account menu

SK&F 102698

Known as: SK&F-102698, SKF 102698 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
The effect of 6-chloro-2,3,4,5-tetrahydro-3-methyl-1-H-3-benzazepine (SKF 86466), a selective nonimidazoline alpha-2 adrenoceptor… 
1991
1991
The acute and chronic effects of a potent selective dopamine beta-hydroxylase inhibitor, SK&F 102698, were assessed in… 
1990
1990
The acute and chronic effects of a potent and selective dopamine β-hydroxylase inhibitor, SK&F 102698 [l-(3,5-difluorobenzyl… 
1990
1990
The acute and chronic effects of a potent and selective dopamine beta-hydroxylase inhibitor, SK&F 102698 [1-(3,5-difluorobenzyl… 
1990
1990
Dopamine (DA) is synthesized in the renal proximal convoluted tubule (PCT) and may act as a paracrine substance at tubular DA-1… 
1988
1988
The novel dopamine beta-hydroxylase (D beta H) inhibitor SK&F 102698 was characterized in vitro with soluble enzyme from bovine… 
1988
1988
The dopamine beta-hydroxylase inhibitor SK&F 102698 was characterized by studying its cardiovascular effects in hypertensive rats… 
1987
1987
The cardiovascular effects of a new class of potent inhibitors of dopamine beta-hydroxylase (DBH) were evaluated in spontaneously… 
Review
1987
Review
1987
The ability to stimulate dopamine receptors in the heart and blood vessels with selective receptor agonists, such as fenoldopam…